Galderma Launches Restylane® VOLYME™ in China - One of the World’s Fastest Growing Aesthetics Markets
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
ZUG, Switzerland -- Businesswire -- Galderma (SWX:GALD) announced today the launch of its hyaluronic acid injectable filler, Restylane® VOLYME™ in China. The company is also introducing its complementary Shape Up Holistic Individualized Treatment (HIT™) in the country, which addresses aging concerns caused by loss of structural support in the mid-face. The availability of these targeted solutions for the mid-face region is demonstrative of Galderma’s commitment to meeting patient and injector needs in China. In the past decade, the growth of China’s aesthetics medicine market has outpaced the global market; with relatively low market penetration, there remains significant potential for future growth.[1]
Developed using Galderma’s proprietary OBT™* gel technology, Restylane® VOLYME™ is indicated for the correction of mid-face volume deficit and/or mid-face contour deficiency through injections into the subcutaneous to supraperiosteal layers of the skin.[2-3] Hyaluronic acid fillers are often patients’ first choice for mid-face augmentation and have been shown to deliver high patient satisfaction and long-lasting effects.[4] In China, hyaluronic acid fillers are among the top 10 most-sold aesthetics products.[1]
“We are delighted to deliver Galderma’s innovative aesthetics solutions in China with the support of our research and development teams, as well as local partners and regulatory authorities. As the Chinese market continues to expand, we look forward to working closely with all stakeholders to deliver our full, premium range of aesthetics products to meet the varied and individual needs of patients and injectors.” GERRY MUHLE HEAD OF GLOBAL PRODUCT STRATEGY GALDERMA
Developed with a global community of injectors, the Shape Up HIT™ is the latest of Galderma’s HITs™ to be introduced in China, designed to create a common language to facilitate a two-way dialogue between patient and practitioner to align on patient priorities and keep satisfaction at the forefront.
“Aesthetic plastic surgery is an artistic creation under medical constraints, embodying a holistic and individualized approach. Facial expressions are controlled by 42 muscles which convey emotions such as joy, anger, sorrow, and happiness. These muscles are also involved in language, chewing, and other activities. The appearance of the mid-face is crucial in interpersonal communication. Together, Restylane® VOLYME™ and the Shape Up HIT™ enable patients to maintain their natural facial expressions while also supporting injectors to deliver a youthful and long-lasting aesthetic effect.” PROFESSOR HAIYAN CUI DIRECTOR OF THE INSTITUTE OF AESTHETIC PLASTIC SURGERY AND MEDICINE TONGJI UNIVERSITY DIRECTOR OF THE PLASTIC & COSMETIC SURGERY DEPARTMENT TONGJI HOSPITAL OF TONGJI UNIVERSITY
HIT™ is an individualized treatment approach which enables injectors to leverage their expertise with the renowned Galderma Restylane® portfolio to optimize aesthetic outcomes while prioritizing patient satisfaction. The Balanced Profile HIT™ was Galderma’s first HIT™ to be introduced in China in 2023, providing a framework for practitioners to conduct a full objective facial assessment for the patient and help bring balance to their profile. HIT™ naturally springboards from Galderma’s AART™ (Assessment, Anatomy, Range, Treatment) methodology for a new generation of individualized aesthetics.
Restylane® is the largest and most diverse range of individually engineered hyaluronic acid fillers on the market, approved in more than 80 countries and regions, and with over 65 million treatments administered worldwide.[5-8]
About Galderma
Galderma (SIX: GALD) is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ - the skin - meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com
Notes and references:
* Optimal Balance Technology - OBT
[1] Deloitte. China Aesthetic Medicine Outlook Report. Accessed May 2024. Available online. [2] Talarico S et al. High patient satisfaction of a hyaluronic acid filler producing enduring full-facial volume restoration: An 18-month open multicenter study. J Dermatol Surg. 2015; 41: 1361-1369. [3] Galderma. Restylane Instructions for Use. [4] Trinh LN & Gupta A. Hyaluronic acid fillers for midface augmentation: A systematic review. Facial Plast Surg. 2021; 37(5): 576-584. [5] Öhrlund A. New method to study the balance of firmness and flexibility for HA fillers. Poster presented at AMWC 2019. [6] Galderma. Data on file. MA-57232. [7] Galderma. Data on file. MA-33939. [8] Galderma. Data on file. QMS-3637.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240522425104/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Galderma
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 싸이월드 창업자·한컴 임원 뭉쳤다… 링크브릭스 ‘호라이즌AI’ 법인 설립 - 뉴스와이어
- LG CNS, 자율이동로봇 기술로 물류 혁신 나선다 - 뉴스와이어
- 라한호텔 ‘해피新이어’ 패키지 출시 - 뉴스와이어
- 힙합 1세대 MC 한새, 세대를 잇다… X·M·Z세대가 뭉친 혁신적 앨범 발매 - 뉴스와이어
- KG 모빌리티 ‘2025 렉스턴’ 라인업 출시… 온라인 전용 스페셜 에디션 동시 공개 - 뉴스와이어
- GS25 ‘오징어 게임’ 상품 250만 개 판매·팝업스토어 총 3만 명 방문 - 뉴스와이어
- 샤크, 진공 청소·물청소·셀프 클리닝까지 한 대에 담은 3-in-1 올인원 물청소기 ‘하이드로백’
- 도쿄관광한국사무소, 메타버스와 현실에서 도쿄 관광을 즐길 수 있는 교류 플랫폼 ‘헬로! 도쿄
- 펄사 게이밍 기어, 35g의 초경량 마우스 ‘Pulsar X2 Crazylight’ 출시 - 뉴스와이어
- 평창송어축제, 100% 당첨·행운의 룰렛·황금송어잡기 현장 이벤트 풍성 - 뉴스와이어